page_slug,page_title,parent_hub_name,parent_hub_url,hero_headline,hero_description,primary_content_title,primary_content_description,key_capabilities_title,capability_1_title,capability_1_description,capability_2_title,capability_2_description,capability_3_title,capability_3_description,capability_4_title,capability_4_description,capability_5_title,capability_5_description,capability_6_title,capability_6_description,why_choose_title,why_choose_1_icon,why_choose_1_title,why_choose_1_description,why_choose_2_icon,why_choose_2_title,why_choose_2_description,why_choose_3_icon,why_choose_3_title,why_choose_3_description,cta_title,cta_description,cta_primary_button_text,cta_primary_button_link
tavr-testing,TAVR Testing Services | GLP Preclinical CRO | Synchrony Labs,Heart Valve Testing,/preclinical-services/cardiovascular-disease-testing/heart-valve-testing,TAVR Testing Services,"Successful aortic valve replacement depends on precise deployment in calcified tissue, complete sealing without paravalvular leak, and preserved blood flow to coronary arteries. We test positioning accuracy, measure hemodynamic performance, and validate whether your TAVR system performs safely across varying anatomies.",What We Test,"TAVR devices must deploy accurately despite heavy calcification, seal completely against irregular tissue, and avoid blocking coronary arteries. Small positioning errors cause permanent pacemaker needs or dangerous leaks. We test whether your valve expands uniformly, whether balloon-inflatable frames maintain position during inflation, and whether self-expanding systems provide consistent radial force.

We measure deployment precision using biplane fluoroscopy that captures valve positioning from multiple angles. Our aortic root models range from normal anatomy to severely calcified bicuspid valves where standard TAVR approaches fail. Pulse duplicator systems measure pressure gradients across your valve while flow imaging reveals paravalvular leak patterns. We quantify coronary ostia clearance, conduction bundle proximity, and sealing effectiveness.

ISO 5840 standards guide our TAVR testing protocols. FDA guidance documents for transcatheter aortic valves inform our study designs, ensuring we generate the hemodynamic benchmarks and safety data your PMA or 510(k) requires. Our GLP-compliant testing addresses balloon-expandable and self-expanding platforms, standard TAVR procedures, and specialized applications including valve-in-valve implantation.",Key Testing Capabilities,Deployment Precision and Anatomical Compatibility,"We measure positioning accuracy across aortic models from small annuli to bicuspid valves. Testing quantifies deployment forces, captures expansion dynamics with high-speed fluoroscopy, and validates whether your system achieves optimal positioning in challenging anatomies where calcification or irregular geometry complicates standard deployment. (48 words)",Paravalvular Leak Measurement and Sealing Validation,"Advanced flow systems quantify leak severity through regurgitant fraction calculations and real-time jet visualization. We identify leak locations, measure sealing skirt effectiveness, and determine whether calcium displacement creates gaps. Testing addresses immediate post-deployment leak and performance after millions of cardiac cycles. (45 words)",Hemodynamic Performance Under Physiological Conditions,"Pulse duplicators replicate aortic pressure and flow conditions while measuring transvalvular gradients, effective orifice area, and coronary flow patterns. We validate ISO 5840 performance requirements, compare hemodynamic benefits of different valve designs, and ensure adequate blood flow throughout complete cardiac cycles. (44 words)",Coronary Flow Preservation and Obstruction Risk,"We measure coronary ostia clearance during deployment and validate flow to coronary arteries. Testing uses specialized models with functional coronary vessels, fluoroscopic visualization during valve expansion, and flow measurement confirming adequate perfusion. Protocols identify obstruction risks before clinical use. (42 words)",Durability Testing and Accelerated Wear Protocols,"Fatigue testing simulates 200-400 million cycles representing decades of valve function. We monitor for frame fractures, leaflet tears, and hemodynamic degradation. Continuous tracking detects early structural failures while measuring whether sealing effectiveness and flow performance persist throughout projected device lifetime. (43 words)",Conduction System Safety and Pacemaker Risk Assessment,"We evaluate valve positioning relative to conduction pathways, measure frame contact with septal tissue, and assess pacemaker implantation risk. Testing validates whether design modifications reduce conduction disturbances or if deeper deployment increases paravalvular leak trade-offs. (38 words)",Why Choose Synchrony for TAVR Testing,Microscope,Complete TAVR Testing Infrastructure,"Our catheterization laboratories feature biplane fluoroscopy, three-dimensional echocardiography, and specialized TAVR deployment equipment. We maintain aortic models spanning normal annuli through severely calcified bicuspid geometries. Both balloon-expandable and self-expanding valve testing capabilities address platform-specific deployment mechanics and performance requirements.",Activity,Decades of Aortic Valve Testing Experience,"We have tested aortic valves for over 40 years, supporting numerous FDA approvals across balloon-expandable and self-expanding platforms. Our team understands TAVR regulatory requirements, ISO 5840 compliance, and the specific performance data FDA reviewers expect for Class III transcatheter cardiac devices. ",CheckCircle,GLP Compliance for FDA Submissions,"Our GLP-compliant protocols provide the documentation quality FDA expects for transcatheter aortic valve submissions. We generate complete data packages addressing deployment safety, hemodynamic performance, paravalvular leak quantification, and durability validation. Our testing supports both PMA applications and 510(k) substantial equivalence demonstrations. ",Ready to Start Your Study?,"Our team is ready to discuss your TAVR platform, deployment approach, and regulatory pathway requirements.",Schedule Consultation,/contact
mitraclip-testing,MitraClip Testing Services | GLP Preclinical CRO | Synchrony Labs,Heart Valve Testing,/preclinical-services/cardiovascular-disease-testing/heart-valve-testing,MitraClip Testing Services,"Successful mitral repair depends on secure leaflet grasping without tissue damage, precise positioning targeting regurgitant jets, and maintained coaptation throughout cardiac cycles. We test grasping forces, measure residual regurgitation, and validate whether your clip creates effective double-orifice repair across varying tissue pathologies.",What We Test,"Edge-to-edge mitral repair requires clips that grasp leaflets securely without tearing tissue, position accurately in moving cardiac structures, and reduce regurgitation without creating excessive stenosis. Too little grasping force allows leaflet slippage while too much damages tissue. We test whether your clip applies optimal pressure, whether grippers hold throughout millions of cardiac cycles, and whether multi-clip strategies achieve adequate repair.

We measure grasping forces using specialized sensors that quantify leaflet compression and holding strength. Our mitral models replicate both degenerative disease with flail leaflets and functional regurgitation from dilated ventricles. Three-dimensional echocardiography visualizes leaflet capture in real-time while flow measurement quantifies residual regurgitation. Testing addresses single and multiple clip deployments across varying mitral anatomies.

ISO 5840 standards guide our transcatheter valve testing protocols. FDA guidance for mitral repair devices informs study designs addressing hemodynamic safety, procedural feasibility, and durability requirements. Our GLP-compliant testing supports PMA submissions for innovative repair technologies and 510(k) applications demonstrating substantial equivalence to established platforms.",Key Testing Capabilities,Leaflet Grasping Force Measurement and Optimization,"We quantify clip closure pressure across leaflet tissue, measure holding strength under physiological loading, and validate whether grasping forces remain adequate after millions of cardiac cycles. Testing determines optimal pressure balancing secure leaflet capture against tissue damage risk. (42 words)",Deployment Accuracy and Positioning Control,"We evaluate positioning precision within moving mitral structures using three-dimensional echocardiography. Testing measures whether delivery systems enable accurate jet targeting, whether independent gripper control improves leaflet capture, and whether clips achieve intended positioning despite cardiac motion throughout deployment sequences. (42 words)",Residual Regurgitation Quantification and Repair Effectiveness,"Advanced flow systems measure regurgitation reduction through regurgitant fraction calculations and jet visualization. We quantify residual leak severity, map remaining leak locations, and determine whether repair achieves adequate regurgitation reduction without creating mitral stenosis that impairs cardiac output. (41 words)",Coaptation Length Validation and Double-Orifice Function,"We measure coaptation length created by leaflet grasping, validate double-orifice configuration effectiveness, and assess whether adequate leaflet tissue bridge forms. Testing determines if clip width provides sufficient coaptation for broad regurgitant jets and whether tissue accommodation occurs throughout cardiac cycles. (43 words)",Multi-Clip Strategy Testing and Device Interaction,"For complex regurgitation requiring multiple clips, we evaluate clip spacing optimization, measure device-device interactions, and quantify cumulative regurgitation reduction. Testing validates whether multi-clip approaches avoid excessive mitral stenosis while achieving adequate repair across large or multiple regurgitant jets. (40 words)",Durability Assessment and Long-Term Stability,"Accelerated fatigue protocols simulate years of cardiac cycles while monitoring gripper integrity, clip arm stability, and maintained leaflet capture. We measure whether grasping forces persist, if tissue response affects clip position, and whether regurgitation reduction remains stable throughout projected device lifetime. (44 words)",Why Choose Synchrony for MitraClip Testing,Zap,Specialized Mitral Repair Testing Capabilities,"Our catheterization laboratories feature three-dimensional echocardiography, transseptal access equipment, and specialized mitral models. We maintain anatomical specimens representing primary degenerative disease and secondary functional regurgitation. Force measurement systems quantify grasping mechanics while advanced flow imaging captures regurgitation patterns. ",Users,Extensive Mitral Device Testing Experience,"We have tested mitral repair devices for decades, supporting FDA approvals across edge-to-edge repair and replacement platforms. Our team understands mitral regurgitation pathophysiology, transcatheter repair challenges, and FDA expectations for Class III mitral devices addressing both primary and secondary regurgitation. ",CheckCircle,GLP-Compliant Regulatory Data Packages,"Our protocols provide documentation meeting FDA requirements for transcatheter mitral repair submissions. We generate complete datasets addressing grasping force validation, residual regurgitation measurement, multi-clip safety, and durability testing. Testing supports PMA applications and 510(k) substantial equivalence demonstrations with ISO 5840 compliance. ",Ready to Start Your Study?,"Our team is ready to discuss your mitral repair device, grasping mechanism, and regulatory pathway.",Schedule Consultation,/contact
sapien-valve-testing,Sapien Valve Testing Services | GLP Preclinical CRO | Synchrony Labs,Heart Valve Testing,/preclinical-services/cardiovascular-disease-testing/heart-valve-testing,Sapien Valve Testing Services,"Successful balloon-expandable TAVR depends on controlled expansion without frame recoil, predictable positioning during balloon inflation, and complete sealing in calcified tissue. We test crimping profile recovery, measure deployment forces during expansion, and validate whether your valve achieves optimal geometry across varying inflation pressures.",What We Test,"Balloon-expandable TAVR systems must crimp to small profiles without damaging leaflets, expand uniformly when inflated, and maintain position without recoil after balloon deflation. We test whether your valve recovers from crimping stress, whether balloon inflation displaces calcium effectively, and whether frame geometry remains stable post-deployment. Testing measures expansion pressures, radial forces, and sealing effectiveness.

We characterize crimping behavior using specialized equipment that measures profile reduction and leaflet integrity. Deployment testing uses controlled balloon inflation while biplane fluoroscopy captures expansion dynamics and calcium displacement. Our calcified aortic models replicate severe stenosis where uneven expansion creates dangerous leaks. Flow measurement systems quantify paravalvular leak patterns specific to balloon-expandable platforms.

ISO 5840 standards guide our balloon-expandable valve testing. FDA guidance for TAVR devices informs protocols addressing deployment safety, hemodynamic benchmarks, and durability requirements. Our GLP-compliant testing supports PMA submissions for innovative balloon-expandable technologies and 510(k) applications demonstrating substantial equivalence to established Sapien platforms.",Key Testing Capabilities,Crimping Profile Validation and Leaflet Integrity,"We measure crimped valve diameter, assess leaflet damage from compression, and validate recovery after expansion. Testing quantifies whether crimping stress causes leaflet tearing or frame deformation. Specialized imaging captures leaflet configuration throughout crimping and re-expansion sequences. (40 words)",Balloon Expansion Mechanics and Deployment Forces,"We measure balloon inflation pressures required for complete expansion, quantify radial forces during deployment, and capture frame geometry development using high-speed fluoroscopy. Testing validates whether expansion occurs uniformly or if calcium creates asymmetric loading that distorts valve shape. (42 words)",Frame Recoil Measurement and Position Stability,"After balloon deflation, we measure frame recoil and position migration. Testing quantifies whether cobalt-chromium frames maintain intended diameter or if elastic recoil reduces effective orifice area. Stability assessment determines if valves shift position after balloon removal. (39 words)",Calcium Displacement and Annular Contact Patterns,"We evaluate how balloon expansion displaces calcium nodules, whether displacement creates complete annular contact, and if uneven calcium distribution causes persistent leak paths. Testing uses heavily calcified models where balloon force distribution determines sealing success. (39 words)",Paravalvular Leak Assessment in Calcified Anatomy,"Advanced flow systems quantify leak severity specific to balloon-expandable deployment. We identify leak locations relative to calcium distribution, measure whether sealing skirts accommodate irregular surfaces, and determine if higher inflation pressures improve sealing without causing annular rupture. (41 words)",Accelerated Durability and Frame Integrity,"Fatigue protocols simulate millions of cardiac cycles while monitoring cobalt-chromium frame stability, bovine pericardial leaflet performance, and suture line integrity. We measure whether balloon expansion creates stress concentrations that accelerate frame fatigue or if deployment damage affects long-term durability. (44 words)",Why Choose Synchrony for Sapien Valve Testing,Microscope,Balloon-Expandable TAVR Testing Infrastructure,"Our laboratories feature precision balloon inflation systems, specialized crimping equipment, and biplane fluoroscopy for expansion visualization. We maintain heavily calcified aortic models and pressure monitoring systems measuring deployment forces. This infrastructure addresses balloon-expandable valve testing requirements that self-expanding valve facilities cannot replicate. ",Activity,Decades of Balloon-Expandable Valve Experience,"We have tested balloon-expandable TAVR systems for years, supporting multiple FDA approvals. Our team understands balloon inflation mechanics, calcium displacement dynamics, and paravalvular leak prevention strategies specific to balloon-expandable platforms. This experience informs protocol designs addressing FDA Class III device requirements. ",CheckCircle,GLP Compliance for FDA Submissions,"Our protocols provide documentation meeting FDA expectations for balloon-expandable TAVR submissions. We generate complete datasets addressing crimping safety, deployment force validation, frame recoil measurement, and sealing technology assessment. Testing supports both PMA applications and 510(k) substantial equivalence demonstrations with ISO 5840 compliance. ",Ready to Start Your Study?,Our team is ready to discuss your balloon-expandable valve platform and regulatory pathway requirements.,Schedule Consultation,/contact
evolut-testing,Evolut Valve Testing Services | GLP Preclinical CRO | Synchrony Labs,Heart Valve Testing,/preclinical-services/cardiovascular-disease-testing/heart-valve-testing,Evolut Valve Testing Services,"Successful repositionable TAVR depends on controlled self-expansion, safe retrieval and redeployment mechanics, and maintained performance after multiple positioning attempts. We test nitinol frame behavior, measure repositioning impact on valve integrity, and validate whether your system enables procedural optimization through recapture functionality.",What We Test,"Repositionable self-expanding TAVR systems must deploy predictably through controlled nitinol expansion, allow retrieval when positioning is suboptimal, and maintain structural integrity through multiple deployment attempts. We test whether your valve's nitinol frame self-expands at consistent rates, whether retrieval mechanisms function safely, and whether performance remains acceptable after recapture and redeployment sequences.

We measure self-expansion rates using specialized monitoring systems that capture frame deployment dynamics. Testing validates retrieval forces, quantifies nitinol stress during recapture, and assesses whether multiple deployment cycles damage leaflets or frame structure. Our aortic models enable repositioning validation across anatomical variations where initial deployment may require adjustment. Supra-annular positioning is evaluated for hemodynamic advantages over intra-annular designs.

ISO 5840 standards guide our self-expanding valve testing. FDA guidance for TAVR devices with repositioning capabilities informs protocols addressing enhanced procedural control and safety validation. Our GLP-compliant testing supports PMA submissions for innovative repositionable technologies and 510(k) applications demonstrating substantial equivalence to established Evolut platforms.",Key Testing Capabilities,Nitinol Frame Self-Expansion and Deployment Control,"We measure self-expansion rates, quantify radial forces throughout deployment, and validate positioning control as the frame releases from delivery sheaths. Testing captures expansion dynamics using high-speed fluoroscopy while measuring whether temperature variations affect deployment predictability. (41 words)",Retrieval and Redeployment Mechanics Validation,"We test whether retrieval mechanisms function reliably, measure forces required for recapture, and validate valve integrity after repositioning. Testing determines how many deployment attempts your system tolerates before structural damage occurs or performance degrades below acceptable thresholds. (41 words)",Repositioning Impact on Valve Performance,"After recapture and redeployment sequences, we measure hemodynamic performance, inspect for leaflet damage, and quantify frame deformation. Testing validates whether repositioning affects paravalvular sealing, if leaflet function remains normal, and whether chronic radial force degrades after multiple deployment attempts. (42 words)",Supra-Annular Positioning and Hemodynamic Advantages,"We measure effective orifice area benefits from elevated leaflet positioning, quantify transvalvular gradient reductions, and compare hemodynamic performance against intra-annular designs. Testing validates whether supra-annular placement provides measurable flow improvements justifying self-expanding platform selection. (38 words)",Chronic Radial Force and Long-Term Stability,"We measure radial forces immediately post-deployment and throughout accelerated aging protocols. Testing determines whether nitinol maintains adequate outward force preventing frame collapse or migration, if chronic loading affects expansion geometry, and whether sealing effectiveness persists throughout projected device lifetime. (43 words)",Nitinol Durability and Fatigue Resistance,"Accelerated fatigue testing simulates millions of cardiac cycles while monitoring nitinol frame integrity. We measure whether repositioning creates stress concentrations accelerating fracture, if high-cycle loading causes frame deformation, and whether porcine pericardial leaflets maintain performance throughout durability protocols. (41 words)",Why Choose Synchrony for Evolut Valve Testing,Settings,Repositionable Valve Testing Infrastructure,"Our laboratories feature specialized equipment for self-expanding valve deployment, nitinol characterization systems, and repositioning mechanism validation capabilities. We maintain anatomical models enabling multiple deployment testing and advanced imaging capturing retrieval and redeployment dynamics. This infrastructure addresses repositionable platform requirements.",Users,Self-Expanding TAVR Testing Experience,"We have tested self-expanding and repositionable TAVR systems for years, supporting FDA approvals. Our team understands nitinol deployment mechanics, retrieval safety requirements, and repositioning validation approaches. This experience informs protocol designs addressing FDA Class III device requirements for innovative repositionable valve technologies. ",CheckCircle,GLP Compliance for Advanced TAVR Systems,"Our protocols provide documentation meeting FDA expectations for repositionable TAVR submissions. We generate datasets addressing retrieval mechanism safety, multiple deployment impact assessment, nitinol durability validation, and supra-annular hemodynamic benefits. Testing supports PMA applications and 510(k) demonstrations with ISO 5840 compliance. ",Ready to Start Your Study?,Our team is ready to discuss your repositionable valve platform and enhanced deployment control features.,Schedule Consultation,/contact
pascal-testing,Pascal Device Testing Services | GLP Preclinical CRO | Synchrony Labs,Heart Valve Testing,/preclinical-services/cardiovascular-disease-testing/heart-valve-testing,Pascal Device Testing Services,"Successful advanced mitral repair depends on independent leaflet grasping control, effective spacer deployment creating tissue bridges, and broad paddle coaptation addressing complex regurgitation. We test independent gripper mechanics, measure spacer technology performance, and validate whether your system achieves superior coaptation compared to conventional edge-to-edge repair.",What We Test,"Advanced mitral repair with independent grippers and spacer technology must grasp leaflets sequentially with separate control, deploy spacers that fill regurgitant gaps, and create broad coaptation areas through paddle design. We test whether independent gripper control improves leaflet capture success, whether spacer deployment forces remain safe, and whether broad paddles enhance repair effectiveness in challenging anatomies like large flail segments.

We measure forces for each independent gripper separately, quantifying sequential leaflet capture mechanics. Spacer deployment testing validates controlled expansion, tissue compression characteristics, and bridge formation effectiveness. Three-dimensional echocardiography captures paddle positioning, coaptation length measurement, and residual leak patterns. Testing compares performance against conventional single-gripper designs across primary and secondary regurgitation pathologies.

ISO 5840 standards guide our mitral device testing. FDA guidance for transcatheter mitral repair informs protocols addressing innovative repair technologies requiring comprehensive safety validation. Our GLP-compliant testing supports PMA submissions for advanced repair systems demonstrating advantages over established edge-to-edge platforms.",Key Testing Capabilities,Independent Gripper Mechanics and Sequential Capture,"We measure individual gripper forces separately, quantify leaflet compression per gripper, and validate sequential capture timing. Testing determines whether independent control improves deployment success in challenging anatomies where simultaneous leaflet capture fails, measuring performance benefits over conventional designs. (41 words)",Spacer Technology Deployment and Tissue Bridge Formation,"We test spacer expansion mechanics, measure deployment forces, and validate tissue bridge creation between leaflets. Testing determines whether spacer compression remains safe for tissue, if bridge formation fills regurgitant gaps effectively, and whether spacer technology enhances repair durability. (41 words)",Broad Paddle Coaptation and Enhanced Surface Area,"We measure coaptation length created by paddle design, quantify contact area between paddles, and validate whether broader coaptation improves repair effectiveness. Testing compares paddle performance against narrower conventional designs, particularly for large flail segments or complex regurgitation patterns requiring enhanced leaflet contact. (44 words)",Regurgitation Reduction in Complex Anatomies,"We quantify repair effectiveness across challenging mitral pathologies including large flail segments, multiple regurgitant jets, and severe functional regurgitation. Testing measures whether independent grippers and spacer technology enable adequate repair where conventional edge-to-edge approaches fail. (39 words)",Multi-Device Strategy and Spacing Optimization,"For severe regurgitation requiring multiple devices, we test optimal spacing between Pascal clips, measure cumulative regurgitation reduction, and validate whether multi-device deployment avoids excessive stenosis. Testing addresses device-device interactions and spacing strategies maximizing repair effectiveness. (38 words)",Durability of Advanced Repair Components,"Accelerated fatigue testing simulates years of cardiac loading while monitoring independent gripper integrity, spacer structural stability, and broad paddle performance. We measure whether advanced features introduce failure modes or if independent mechanics and spacer technology maintain long-term effectiveness. (42 words)",Why Choose Synchrony for Pascal Device Testing,Layers,Advanced Mitral Repair Testing Capabilities,"Our laboratories feature force measurement systems quantifying independent gripper mechanics, specialized equipment validating spacer deployment, and imaging capturing broad paddle coaptation. We maintain complex mitral anatomical models including large flail segments and severe functional regurgitation where advanced repair technologies demonstrate advantages. ",Users,Innovative Mitral Device Testing Experience,"We have tested advanced mitral repair technologies incorporating independent grippers and novel repair mechanisms. Our team understands comparative testing requirements demonstrating advantages over predicate devices, particularly when innovative features address limitations of conventional edge-to-edge repair. ",CheckCircle,PMA Pathway Support for Innovative Technologies,"Our protocols provide documentation for PMA submissions requiring comprehensive safety and effectiveness validation. We generate comparative datasets addressing independent gripper advantages, spacer technology safety, and enhanced coaptation benefits over conventional designs. Testing meets FDA expectations for Class III innovative mitral devices. ",Ready to Start Your Study?,Our team is ready to discuss your advanced mitral repair technology and PMA pathway requirements.,Schedule Consultation,/contact
tendyne-testing,Tendyne Testing Services | GLP Preclinical CRO | Synchrony Labs,Heart Valve Testing,/preclinical-services/cardiovascular-disease-testing/heart-valve-testing,Tendyne Testing Services,"Successful transapical mitral replacement depends on secure apical anchoring without ventricular dysfunction, D-shaped frame expansion accommodating elliptical annuli, and optimal tether tension balancing stability against cardiac mechanics. We test apical delivery forces, measure tether tension ranges, and validate whether your D-shaped frame achieves complete mitral sealing.",What We Test,"Transapical mitral replacement with tether anchoring must deliver valves safely through ventricular walls, expand D-shaped frames conforming to elliptical mitral geometry, and maintain position through tether tension without constraining cardiac function. We test whether apical access creates acceptable tissue trauma, whether tether forces secure valves adequately, and whether D-shaped expansion achieves paravalvular sealing in irregular mitral annuli.

We measure apical delivery insertion forces, quantify tissue trauma from ventricular penetration, and validate closure adequacy. Tether tension testing uses force sensors measuring optimal ranges preventing migration while avoiding excessive ventricular constraint. D-shaped frame testing validates expansion across varying mitral geometries using anatomical models representing annular irregularities. Hemodynamic assessment measures transvalvular gradients and flow patterns specific to mitral position.

ISO 5840 standards guide our mitral valve testing. FDA guidance for transcatheter mitral devices informs protocols addressing transapical access safety, tether anchoring validation, and mitral hemodynamic benchmarks. Our GLP-compliant testing supports PMA submissions for innovative mitral replacement technologies where limited predicate devices require comprehensive safety and effectiveness demonstration.",Key Testing Capabilities,Apical Delivery Safety and Access Validation,"We measure ventricular insertion forces, quantify tissue trauma from apical access, and validate hemostasis after catheter removal. Testing determines whether delivery causes acceptable damage to ventricular walls and if apical closure techniques prevent bleeding. Chronic studies assess healing and tissue response. (45 words)",Tether Tension Optimization and Anchoring Mechanics,We measure optimal tether force ranges securing apical anchoring without constraining ventricular function. Testing quantifies whether tether tension prevents valve migration during cardiac contraction while avoiding excessive wall stress. Force measurement validates whether anchoring remains adequate throughout cardiac cycles and chronic loading. (44 words),D-Shaped Frame Expansion and Mitral Accommodation,"We test frame expansion across elliptical mitral annuli, validate D-shaped geometry conformation to irregular anatomies, and measure whether frame design achieves complete annular contact. Testing addresses varying mitral dimensions and asymmetric annular shapes where circular frames fail to seal adequately. (43 words)",Paravalvular Sealing in Irregular Mitral Anatomy,"Flow measurement quantifies leak severity specific to mitral position where annular irregularities complicate sealing. We identify leak locations, measure sealing effectiveness across D-shaped frame contact areas, and determine whether fabric skirts accommodate tissue variations. Testing addresses mitral-specific sealing challenges. (42 words)",Mitral Hemodynamics and LVOT Obstruction Risk,"Pulse duplicators measure transvalvular gradients, effective orifice area, and left ventricular outflow tract flow patterns. We validate whether valve positioning obstructs outflow, if mitral gradients remain acceptable, and whether cardiac output is preserved. Testing addresses mitral-specific hemodynamic requirements. (42 words)",Tether Durability and Long-Term Anchoring,"Accelerated fatigue testing simulates years of cardiac loading while monitoring tether integrity and apical anchoring stability. We measure whether tether materials resist fatigue, if apical pad remains secure, and whether ventricular wall response affects long-term positioning. Chronic studies assess tissue integration. (44 words)",Why Choose Synchrony for Tendyne Testing,Anchor,Transapical Mitral Replacement Infrastructure,"Our laboratories feature transapical access simulation equipment, tether force measurement systems, and specialized mitral anatomical models with D-shaped annular configurations. We maintain three-dimensional echocardiography for frame expansion visualization and hemodynamic systems measuring mitral position performance. This infrastructure addresses transapical replacement challenges. ",Users,Innovative Mitral Device Testing Experience,"We have tested transcatheter mitral devices across repair and replacement categories. Our team understands mitral replacement challenges including apical access risks, tether mechanics, and D-shaped frame requirements. This experience informs protocol designs addressing FDA Class III device requirements for breakthrough mitral replacement technologies. ",CheckCircle,PMA Pathway Support for Mitral Replacement,"Our protocols provide documentation for PMA submissions requiring comprehensive safety demonstration. We generate datasets addressing apical access safety, tether anchoring validation, D-shaped frame sealing effectiveness, and mitral hemodynamic performance. Testing meets FDA expectations for innovative Class III transcatheter mitral devices with limited predicate options. ",Ready to Start Your Study?,Our team is ready to discuss your transapical mitral replacement device and PMA pathway requirements.,Schedule Consultation,/contact
triclip-testing,TriClip Testing Services | GLP Preclinical CRO | Synchrony Labs,Heart Valve Testing,/preclinical-services/cardiovascular-disease-testing/heart-valve-testing,TriClip Testing Services,"Successful tricuspid repair depends on secure leaflet grasping across heterogeneous tissue quality, effective multi-clip strategies addressing severely dilated annuli, and adequate regurgitation reduction in low-pressure right heart environments. We test grasping forces across anterior, posterior, and septal leaflets, measure repair effectiveness in extreme dilation, and validate right heart hemodynamic performance.",What We Test,"Tricuspid edge-to-edge repair faces unique challenges beyond mitral applications. Tricuspid leaflets vary dramatically in thickness and texture from thin septal to thick anterior tissue. Annular dilation often exceeds 50mm, far beyond mitral dimensions. Right heart pressure is one-fifth of left heart, changing hemodynamic requirements. We test whether clips grasp heterogeneous leaflets securely, whether multi-clip strategies achieve adequate repair in massive dilation, and whether low venous pressure affects device performance.

We measure grasping forces separately for each leaflet type, quantifying tissue compression across thin and thick variations. Testing validates multi-clip spacing strategies for severely dilated annuli where single clips fail. Right heart anatomical models replicate extreme tricuspid dilation and varying leaflet morphologies. Hemodynamic measurement addresses low-pressure performance and cardiac output preservation throughout repair assessment.

ISO 5840 standards guide our tricuspid device testing. FDA guidance for transcatheter tricuspid interventions informs protocols addressing right heart device safety and effectiveness validation. Our GLP-compliant testing supports PMA submissions for tricuspid therapies where limited predicate devices and unique anatomical challenges require comprehensive safety demonstration.",Key Testing Capabilities,Heterogeneous Leaflet Grasping Across Tissue Quality,"We measure grasping forces separately for anterior, posterior, and septal leaflets with varying thickness and texture. Testing determines whether clips achieve secure capture across thin septal tissue and thick anterior leaflets, measuring optimal forces accommodating tricuspid heterogeneity. (42 words)",Multi-Clip Strategy for Severe Annular Dilation,"We test clip spacing optimization in annuli exceeding 50mm where single devices fail. Testing measures cumulative regurgitation reduction with multiple clips, validates whether multi-device deployment avoids excessive stenosis, and determines optimal spacing patterns for extreme dilation. (40 words)",Right Heart Hemodynamic Performance Validation,"We measure tricuspid gradients, right atrial pressures, and cardiac output throughout repair assessment. Testing validates whether repair maintains adequate flow in low-pressure venous environments, if stenosis risk increases with multiple clips, and whether right heart function improves after regurgitation reduction. (44 words)",Repair Effectiveness in Complex Regurgitation Patterns,We quantify regurgitation reduction across multiple jets and broad coaptation gaps characteristic of severe tricuspid disease. Testing measures whether edge-to-edge repair achieves adequate reduction when leaflet tethering and annular dilation create complex regurgitation patterns beyond simple central jets. (42 words),Right Heart Access and Delivery System Performance,"We validate transjugular and transfemoral venous access approaches, measuring catheter navigation through right atrium to tricuspid valve. Testing addresses delivery system performance in dilated right hearts where increased chamber size complicates device positioning and leaflet targeting. (41 words)",Durability in Low-Pressure Environments,"Accelerated fatigue testing simulates years of venous pressure loading while monitoring clip integrity and leaflet capture. We measure whether low-pressure environments affect device performance differently than left heart applications, if grasping forces remain adequate, and whether tissue response differs in right heart positions. (47 words)",Why Choose Synchrony for TriClip Testing,Triangle,Specialized Tricuspid Repair Testing Infrastructure,"Our laboratories feature right heart anatomical models with severely dilated tricuspid annuli, heterogeneous leaflet specimens, and low-pressure hemodynamic systems. We maintain force measurement capabilities addressing tissue quality variations and imaging systems capturing multi-clip deployment in complex anatomies. This infrastructure addresses tricuspid-specific testing challenges. ",Users,Right Heart Device Testing Experience,"We have tested transcatheter tricuspid devices addressing unique right heart challenges. Our team understands tricuspid anatomical heterogeneity, severe annular dilation management, and right heart hemodynamic requirements. This experience informs protocol designs addressing FDA Class III device requirements for innovative tricuspid therapies. ",CheckCircle,PMA Pathway Support for Tricuspid Devices,"Our protocols provide documentation for PMA submissions in tricuspid repair where limited predicates require comprehensive effectiveness demonstration. We generate datasets addressing leaflet heterogeneity, multi-clip safety, severe dilation management, and right heart hemodynamics. Testing meets FDA expectations for Class III transcatheter tricuspid devices. ",Ready to Start Your Study?,Our team is ready to discuss your tricuspid repair device and right heart testing requirements.,Schedule Consultation,/contact
corevalve-testing,CoreValve Testing Services | GLP Preclinical CRO | Synchrony Labs,Heart Valve Testing,/preclinical-services/cardiovascular-disease-testing/heart-valve-testing,CoreValve Testing Services,"Successful self-expanding TAVR depends on predictable nitinol deployment without balloon inflation, adequate radial force maintaining annular seal, and supra-annular leaflet positioning maximizing flow area. We test nitinol frame mechanics, measure chronic radial forces, and validate whether your self-expanding valve achieves hemodynamic advantages over intra-annular designs.",What We Test,"Self-expanding TAVR with nitinol frames must deploy predictably through controlled self-expansion, provide adequate radial force for paravalvular sealing, and demonstrate supra-annular positioning benefits. We test whether nitinol behaves consistently across temperature variations, whether radial forces prevent migration without excessive annular stress, and whether elevated leaflet placement improves effective orifice area compared to intra-annular valve positions.

We measure nitinol transformation temperatures, quantify radial force distribution across frame geometry, and capture self-expansion rates using high-speed fluoroscopy. Testing validates whether temperature fluctuations affect deployment predictability, whether chronic radial force maintains sealing throughout accelerated aging, and whether nitinol fatigue resistance meets durability requirements. Hemodynamic assessment measures supra-annular positioning advantages through flow area quantification and gradient reduction.

ISO 5840 standards guide our self-expanding valve testing. FDA guidance for TAVR devices informs protocols addressing nitinol safety, chronic radial force requirements, and hemodynamic performance benchmarks. Our GLP-compliant testing supports PMA submissions for innovative self-expanding technologies and 510(k) applications demonstrating substantial equivalence to established platforms.",Key Testing Capabilities,Nitinol Framework Mechanics and Material Properties,"We measure transformation temperatures, quantify stress-strain relationships, and validate superelastic recovery across temperature ranges. Testing characterizes radial force distribution, chronic outward force maintenance, and temperature-dependent deployment dynamics. Material testing identifies whether nitinol properties meet performance requirements. (40 words)",Self-Expansion Deployment Control and Predictability,"We measure self-expansion rates during frame release, quantify deployment control throughout unsheathing, and validate positioning accuracy. High-speed fluoroscopy captures expansion dynamics while testing determines whether temperature variations affect deployment predictability or if controlled release maintains positioning precision. (40 words)",Chronic Radial Force and Paravalvular Sealing,"We measure radial forces immediately post-deployment and throughout accelerated aging protocols. Testing quantifies whether outward force provides adequate annular contact for sealing without excessive tissue stress, if force distribution patterns prevent leak, and whether chronic loading maintains sealing effectiveness. (43 words)",Supra-Annular Hemodynamic Performance Benefits,"Pulse duplicators measure effective orifice area advantages from elevated leaflet positioning, quantify transvalvular gradient reductions, and compare flow patterns against intra-annular designs. Testing validates whether supra-annular placement provides measurable hemodynamic improvements justifying self-expanding platform selection. (38 words)",Nitinol Fatigue Resistance and Frame Durability,"Accelerated fatigue testing simulates millions of cardiac cycles while monitoring nitinol framework for fractures or deformation. We measure high-cycle fatigue performance, identify stress concentration locations, and validate whether frame maintains structural integrity throughout projected device lifetime. (39 words)",Temperature Stability and Deployment Consistency,"We test deployment across clinically relevant temperature ranges, measuring whether variations affect expansion rates, radial forces, or positioning accuracy. Testing validates whether procedural temperature fluctuations create unpredictable deployment behaviors or if nitinol maintains consistent performance. (38 words)",Why Choose Synchrony for CoreValve Testing,Settings,Self-Expanding Valve Testing Infrastructure,"Our laboratories feature nitinol characterization equipment, controlled deployment monitoring systems, and supra-annular hemodynamic assessment capabilities. We maintain temperature-controlled testing environments, material testing equipment for nitinol properties, and specialized aortic models validating self-expanding platform performance. This infrastructure addresses self-expanding valve requirements. ",Activity,Decades of Self-Expanding TAVR Experience,"We have tested self-expanding aortic valves for years, supporting multiple FDA approvals. Our team understands nitinol deployment mechanics, chronic radial force requirements, and supra-annular positioning advantages. This experience informs protocol designs addressing FDA Class III device requirements for self-expanding valve technologies. ",CheckCircle,GLP Compliance for Nitinol Valve Submissions,"Our protocols provide documentation meeting FDA expectations for self-expanding TAVR submissions. We generate datasets addressing nitinol material validation, chronic radial force measurement, supra-annular hemodynamic benefits, and durability testing. Testing supports PMA applications and 510(k) demonstrations with ISO 5840 compliance. ",Ready to Start Your Study?,Our team is ready to discuss your self-expanding valve platform and nitinol framework requirements.,Schedule Consultation,/contact